Trending Now
Stocks Poised to Draw Attention as Sustainability Favorites Ahead (NEE, BLQC,...
As growth stocks pull back in 2022, investors face what could be a defining long-term investment opportunity (1). When the streets run...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Alumis Inc (ALMS) Takes a Bold Step Forward with Its Initial...
Alumis Inc., a pioneering biopharmaceutical company, is making headlines with its recent announcement on June 27, 2024. Known for its innovative approach...
MAKE IT MODERN
LATEST REVIEWS
Peloton’s ($PTON) Rocky Fiscal Fourth Quarter: A Dive into Subscriber Drop...
Shares of Peloton (NASDAQ:PTON), the renowned fitness equipment and media company, plummeted about 23% in early trading on Wednesday. The dip...
MAKE IT MODERN
PERFORMANCE TRAINING
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Announces Its Focus And Progress Across Its ATTR Amyloidosis Programs
When a team of distinguished scientific leaders came together in 2002, they did not know that their vision would forever transform people's lives. Their...
Why SGMD May be one of the Top Cannabis Growth Plays
One is wise to focus on one pivotal fact about a publicly traded almost more than any other: does it overpromise and underdeliver, or...
SPDR S&P 500 ETF Trust (SPY) wobbles post strong job report
SPY is currently trading at 381.45 -2.31 (-0.60%). However, Futures are red after a strong jobs report just hit this morning. Reason...
AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) Reports Study Progress of Ampligen Combination As COVID-19 Treatment
AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) has announced positive development in advancing preventive strategies and treatment for SARS-CoV-2 caused by COVID-19 disease.
ZyVersa Therapeutics, Inc. (ZVSA): A 38.8% Stock Surge Highlights Innovative Approach to Inflammatory Disease...
ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA), a clinical-stage specialty biopharmaceutical company based in Weston, Florida, saw a significant stock boost of 38.8%, closing...
MAKE IT MODERN
